Goldman Sachs Group Inc Ac Immune Sa Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Ac Immune Sa stock. As of the latest transaction made, Goldman Sachs Group Inc holds 10,369 shares of ACIU stock, worth $32,662. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,369

Holding current value

$32,662

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.48 - $2.2 $15,346 - $22,811	10,369 New	10,369 $21,000
Q3 2024 Nov 14, 2024	SELL	$2.99 - $4.2 $2,009 - $2,822	-672 Reduced 5.04%	12,657 $47,000
Q2 2024 Aug 13, 2024	SELL	$2.29 - $4.87 $23,541 - $50,063	-10,280 Reduced 43.54%	13,329 $53,000
Q1 2024 May 15, 2024	BUY	$2.66 - $4.87 $16,808 - $30,773	6,319 Added 36.55%	23,609 $69,000
Q4 2023 Feb 13, 2024	BUY	$2.46 - $5.0 $42,533 - $86,450	17,290 New	17,290 $86,000
Q4 2022 May 14, 2024	SELL	$1.72 - $3.12 $13,261 - $24,055	-7,710 Reduced 29.01%	18,867 $38,000
Q4 2022 Feb 13, 2023	SELL	$1.72 - $3.12 $13,261 - $24,055	-7,710 Reduced 29.01%	18,867 $38,000
Q3 2022 May 14, 2024	SELL	$2.4 - $3.64 $5,532 - $8,390	-2,305 Reduced 7.98%	26,577 $84,000
Q3 2022 Nov 10, 2022	SELL	$2.4 - $3.64 $5,532 - $8,390	-2,305 Reduced 7.98%	26,577 $83,000
Q2 2022 May 14, 2024	BUY	$2.35 - $4.47 $27,241 - $51,816	11,592 Added 67.04%	28,882 $104,000
Q2 2022 Aug 15, 2022	BUY	$2.35 - $4.47 $176 - $335	75 Added 0.26%	28,882 $104,000
Q1 2022 May 16, 2022	BUY	$3.5 - $5.16 $7,644 - $11,269	2,184 Added 8.2%	28,807 $115,000
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $34,138 - $53,434	-7,068 Reduced 20.98%	26,623 $132,000
Q3 2021 Nov 10, 2021	BUY	$6.2 - $8.34 $208,884 - $280,982	33,691 New	33,691 $226,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

26.9M

Call Options Held

Put Options Held

28.5K

Bvf Inc San Francisco, CA

19.8M
Shares

$62.4 Million
1.58% of portfolio
Black Rock Inc. New York, NY

2.61M
Shares

$8.21 Million
0.0% of portfolio
Wells Fargo & Company San Francisco, CA

1.02M
Shares

$3.23 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

828K
Shares

$2.61 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

412K
Shares

$1.3 Million
0.0% of portfolio

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $263M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account